Amarantus Bioscience Holdings (Amarantus Bioscience Holdings) Market Cap : $0.06 Mil (As of May. 28, 2024)

View and export this data going back to 2008. Start your Free Trial

What is Amarantus Bioscience Holdings Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Amarantus Bioscience Holdings's share price for the quarter that ended in Dec. 2015 was $0.64. Amarantus Bioscience Holdings's Shares Outstanding (EOP) for the quarter that ended in Dec. 2015 was 21.18 Mil. Therefore, Amarantus Bioscience Holdings's market cap for the quarter that ended in Dec. 2015 was $13.55 Mil.

Amarantus Bioscience Holdings's quarterly market cap increased from Dec. 2013 ($45.82 Mil) to Dec. 2014 ($69.23 Mil) but then declined from Dec. 2014 ($69.23 Mil) to Dec. 2015 ($13.55 Mil).

Amarantus Bioscience Holdings's annual market cap increased from Dec. 2013 ($45.82 Mil) to Dec. 2014 ($69.23 Mil) but then declined from Dec. 2014 ($69.23 Mil) to Dec. 2015 ($13.55 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Amarantus Bioscience Holdings's Enterprise Value for Today is $0.06 Mil.

Amarantus Bioscience Holdings Market Cap Historical Data

The historical data trend for Amarantus Bioscience Holdings's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Amarantus Bioscience Holdings Market Cap Chart

Amarantus Bioscience Holdings Annual Data

Trend

Oct08

Oct09

Oct10

Dec11

Dec12

Dec13

Dec14

Dec15

Market Cap

Get a 7-Day Free Trial

10.93

45.21

45.82

69.23

13.55

Amarantus Bioscience Holdings Semi-Annual Data
	Oct08	Oct09	Oct10	Dec11	Dec12	Dec13	Dec14	Dec15
Market Cap	Get a 7-Day Free Trial			10.93	45.21	45.82	69.23	13.55

Competitive Comparison of Amarantus Bioscience Holdings's Market Cap

For the Biotechnology subindustry, Amarantus Bioscience Holdings's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Amarantus Bioscience Holdings's Market Cap Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Amarantus Bioscience Holdings's Market Cap distribution charts can be found below:

* The bar in red indicates where Amarantus Bioscience Holdings's Market Cap falls into.

Amarantus Bioscience Holdings Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Amarantus Bioscience Holdings's Market Cap for the fiscal year that ended in Dec. 2015 is calculated as

Market Cap (A: Dec. 2015 )	=	Share Price (A: Dec. 2015 )	*	Shares Outstanding (EOP) (A: Dec. 2015 )
	=	$0.64	*	21.1773
	=	$13.55

Amarantus Bioscience Holdings's Market Cap for the quarter that ended in Dec. 2015 is calculated as

Market Cap (Q: Dec. 2015 )	=	Share Price (Q: Dec. 2015 )	*	Shares Outstanding (EOP) (Q: Dec. 2015 )
	=	$0.64	*	21.1773
	=	$13.55

Amarantus Bioscience Holdings (OTCPK:AMBS) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

Amarantus Bioscience Holdings Market Cap Related Terms

Thank you for viewing the detailed overview of Amarantus Bioscience Holdings's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.

Amarantus Bioscience Holdings (Amarantus Bioscience Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Amarantus Bioscience Holdings Inc (OTCPK:AMBS) » Definitions » Market Cap

Comparable Companies

Traded in Other Exchanges

N/A

Address

45 Wall Street, Suite 920, New York, NY, USA, 10005

Website

http://www.amarantus.com

Amarantus Bioscience Holdings Inc is a biopharmaceutical company. It is focused on developing therapeutic products for orphan drug designation in the areas of neurology, psychiatry, ophthalmology and regenerative medicine, and diagnostics in neurology. The company's prime therapeutic program, eltoprazine is a small molecule indicated for the treatment of Levodopa-induced dyskinesia. The group's diagnostics division is dedicated to the development and commercialization of neurology diagnostic products. Its diagnostic product, LymPro Test is a blood-based assay to diagnose Alzheimer's disease.

Executives

Flanigan Conn	other: Former Director	1601 BLAKE STREET, SUITE 310, DENVER CO 80202
Robert Edward Farrell	officer: CFO	BIOVEST INTERNATIONAL, INC., 300 S HYDE PARK AVENUE, SUITE 210, TAMPA FL 33606
Joseph Rubinfeld	director	C/O SUPERGEN INC, 4140 DUBLIN BLVD STE 200, DUBLIN CA 94568